Business Context and Reporting Period
Company: Kewaunee Scientific Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended October 31, 2002
Business Overview: The Company manufactures laboratory and technical products. During the quarter, it announced the relocation of its technical products business from Lockhart, Texas, to Statesville, North Carolina.
Key Financial Metrics
| Metric | 3 Months Ended Oct 31, 2002 | 6 Months Ended Oct 31, 2002 |
|---|---|---|
| Net Sales | $19.9 million | $39.3 million |
| Gross Profit | $3.3 million | $6.8 million |
| Gross Margin | 16.8% | 17.3% |
| Operating Earnings (Loss) | ($0.2) million | $0.3 million |
| Net Earnings (Loss) | ($0.1) million | $0.2 million |
| Diluted EPS | ($0.05) | $0.08 |
| Cash from Operations | N/A | $1.0 million |
| Working Capital | $14.3 million | N/A |
| Short-term Borrowings | $0.3 million | N/A |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 11.6% for the quarter and 7.0% for the six-month period compared to the prior year. Laboratory product sales dropped 13.0% (quarter) and 6.5% (six months), attributed to timing of customer delivery requirements.
- Profitability Impact: The Company recorded an operating loss of $192,000 for the quarter, compared to operating earnings of $992,000 in the prior year. Net loss for the quarter was $124,000 versus net earnings of $638,000 previously.
- Non-Recurring Charges: Total pre-tax non-recurring charges of approximately $729,000 impacted the six-month results. This includes $550,000 in cost of sales (inventory write-downs and accelerated depreciation) and $179,000 in operating expenses related to the relocation of the technical products business.
- Cash Flow: Operating cash flow improved significantly to $1.0 million for the six months ended October 31, 2002, compared to a cash use of $11,000 in the prior year period.
Guidance, Outlook, and Risks
- Relocation Costs: The Company estimates total pre-tax costs for the technical products relocation to be approximately $1.0 million. $379,000 was recorded in the current quarter, with the remainder expected in the third and fourth quarters.
- Asset Disposal: Upon completion of the relocation, the Company expects to dispose of the Lockhart, Texas facility for an amount exceeding its $1.3 million net book value.
- Legal Contingency: A $1.3 million judgment against the Company regarding a dispute with Bernards Bros. Inc. was overturned by the Court of Appeals and returned to the Trial Court. Management believes the final liability will match the amount previously recorded.
- Liquidity: Management believes funds from operations and short-term borrowings (currently $346,000 outstanding under a $6.0 million line) are sufficient to support operations and capital expenditures through the fiscal year.
Investor Verification Checklist
- Verify the timing and magnitude of the remaining $621,000 in estimated relocation costs to be incurred in the third and fourth quarters.
- Monitor the final resolution of the Bernards Bros. Inc. litigation to confirm the liability remains at the previously recorded $1.3 million.
- Assess the impact of the "timing of customer delivery requirements" on future laboratory product sales trends.
- Review the expected proceeds from the sale of the Lockhart, Texas facility to confirm they exceed the $1.3 million net book value.
- Confirm the effectiveness of cost-cutting measures in the technical products segment following the relocation.